Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

NGS panel enhance precise diagnosis of myeloid neoplasms under WHO-HAEM5 and International Consensus Classification: An observational study.

Medicine - 14 Jun 2024

Ye Xiangjun, Zheng Zhikang, Wu Yuwei, Zhang Zhihui, Xu Zhiping, Liu Yameng, Jiang Lei, Wu Jianguo

Abstract excerpt

This study aimed to assess hematological diseases next-generation sequencing (NGS) panel enhances the diagnosis and classification of myeloid neoplasms (MN) using the 5th edition of the WHO Classification of Hematolymphoid Tumors (WHO-HAEM5) and the International Consensus Classification (ICC) of Myeloid Tumors. A cohort of 112 patients diagnosed with MN according to the revised fourth edition of the WHO...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Calreticulin
Share to High-Throughput Nucleotide Sequencing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Janus Kinase 2

Share to Leukemia, Myeloid, Acute

Share to Myelodysplastic Syndromes

Share to Myeloproliferative Disorders

Share to Receptors, Thrombopoietin

Share to World Health Organization

Source

Open in PubMed Open full text

Identifiers

PMID: 38875377
DOI: 10.1097/MD.0000000000038556
PMCID: PMC11175920

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

NGS panel enhance precise diagnosis of myeloid neoplasms under WHO-HAEM5 and International Consensus Classification: An observational study.PMID 38875377Read ↗

Advances towards genome-based acute myeloid leukemia classification: A comparative analysis of WHO-HAEM4R, WHO-HAEM5, and International Consensus Classification.Semantic proximity Read ↗

Myeloid neoplasms in the World Health Organization 2016 classification.Semantic proximity Read ↗

Navigating diagnostic shifts: A comparative review of the WHO 5th edition and ICC 2022 classifications of myeloid neoplasms.Semantic proximity Read ↗

Acute Myeloid Leukemia and Next-Generation Sequencing Panels for Diagnosis: A Comprehensive Review.Semantic proximity Read ↗

The international consensus classification of myeloid neoplasms and acute Leukemias: myeloproliferative neoplasms.Semantic proximity Read ↗

World Health Organization Classification, Evaluation, and Genetics of the Myeloproliferative Neoplasm VariantsSemantic proximity Read ↗

14,441 Genomics-Based Validated Automated Comprehensive Clinicopathologic Correlations for Myeloid Neoplasms.Semantic proximity Read ↗

Advances in myelodysplastic/myeloproliferative neoplasms.Semantic proximity Read ↗

Changes in the World Health Organization 2016 classification of myeloid neoplasms everyone should know.Semantic proximity Read ↗

Myelodysplastic and myeloproliferative neoplasms: updates on the overlap syndromes.Semantic proximity Read ↗

Analytical Validation of a 37-Gene Next-Generation Sequencing Panel for Myeloid Malignancies and Review of Initial Findings Incorporating Updated 2022 Diagnostic and Prognostic Guidelines.Semantic proximity Read ↗

Implications of the 5th Edition of the World Health Organization Classification and International Consensus Classification of Myeloid Neoplasm in Myelodysplastic Syndrome With Excess Blasts and Acute Myeloid Leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.